Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Alumis Inc. (ALMS) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Alumis Inc. (ALMS), most recent 12 months reported: revenue $7.4M, net loss $438.96M, free cash flow -$351.8M. Latest balance sheet on file: liquid cash $502.29M. From SEC filings. Others in Pharmaceutical Preparations: Aclaris Therapeutics, Inc. · Coya Therapeutics, Inc. · Adagene Inc. · ROIVANT SCIENCES LTD. · NewAmsterdam Pharma Company N.V. · HCW Biologics Inc. · RANI THERAPEUTICS HOLDINGS, INC. · Bolt Biotherapeutics, Inc.

Stock screener

Watchlist